Ariadne Licenses PathwayStudio® to UCB
News Jan 13, 2006
PathwayStudio comes with ResNet™ database of 500,000+ functional relationships and MedScan™ modules for automatic extraction of information from scientific literature.
The software is designed to enable life science researchers to interpret their own discoveries in the context of biological pathways and gene regulation networks; it makes it easy to identify relationships among proteins, small molecules, cell processes and treatments, reconstruct pathways from microarray and proteomics data, identify biomarkers, and model drug responses.
"PathwayStudio being a client-server application offers pharmaceutical research groups easy and flexible team-wide access to the database, as well as the power of whole PubMed data at their fingertips," commented Ilya Mazo, President of Ariadne Genomics.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.